Moffitt Study Reveals Promising Targeted Therapy Breakthrough for NRAS-Mutant Melanoma
In a groundbreaking advancement for cancer therapeutics, researchers at Moffitt Cancer Center have unveiled the first clinical evidence supporting the efficacy of a RAS inhibitor...















